NuVasive, Incorporated

NuVasive, Incorporated has 1 AI-enabled medical device on the FDA list. The first decision was on June 29, 2018 and the most recent on June 29, 2018 (NuVasive Pulse System). Its most common review panel is Neurology (1 device).